Skip to main content
Premium Trial:

Request an Annual Quote

U of Vermont Health Network Launches DNA Risk Screening Pilot Program

NEW YORK – The University of Vermont Health Network has launched a pilot program to offer DNA testing as part of routine medical care to detect patients' risks for diseases such as cancer and heart disease. 

The health system said Wednesday that the 12-month pilot began Nov. 1 at UVM's primary care sites. UVM Health Network is looking to screen about 1,000 adult patients who participate in the OneCare Vermont accountable care organization.

Invitae will provide the testing, which assesses 147 genes that are considered "well-established" indicators of risk for certain diseases. The San Francisco-based company will also screen for carrier status for other conditions. UVM Health Network will offer follow-up testing for family members when appropriate. The test, as well as genetic counseling with UVM Health Network's Genomic Medicine Resource Center, is free to patients in the pilot program.

"Vermont and other states are moving away from 'fee-for-service' healthcare and toward a system that emphasizes prevention, keeping people healthy and treating illness at its earliest stages," Debra Leonard, chair of pathology and laboratory medicine at UVM, said in a statement. "Integrating genetic risks into clinical care will help patients and providers in their decision-making."

UVM Health Network also is partnering with LunaPBC, the public-benefit corporation that operates the LunaDNA genomic data-sharing platform. Patients who opt for genomic testing will have the choice to share their results with researchers through LunaDNA.  

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.